Drug Chatter -- Tracking biopharma stock chatter

Profile for Osiris Therapeutics, Inc. (OSIR)

« Back to company index

OSIR Chatter Timeline

Stock Ticker for OSIR

Most Active Tweeters for OSIR

UserTweets
@biotechfan20 4
@ledgerzette 1
@mikea1028 1
@Min_Manipulated 1
@rc08610 1

Recent Tweets for OSIR

rc08610 @rc08610
$mdxg v $osir lawsuit - new Jan 11th filing - mediation failed & heading toward discovery this spring. https://t.co/tprhwTMchg
January 15th 2018, 10:01am
WeekHerald @WeekHerald
Head-To-Head Comparison: Soligenix $SNGX and Osiris Therapeutics $OSIR https://t.co/fSOiSKVQyR
January 13th 2018, 7:01am
AmericanBanking @AmericanBanking
Head-To-Head Comparison: Soligenix $SNGX and Osiris Therapeutics $OSIR https://t.co/NTgM679Cz6 #stocks
January 13th 2018, 3:01am
biotechfan20 @biotechfan20
For those new to $OSIR, here is some background https://t.co/7QCvlMNTQU
January 12th 2018, 9:01am
Min_Manipulated @Min_Manipulated
PP appeared to confirm the SEC investigation of $MDXG is out of Denver. Must be the go to team based on their $OSIR… https://t.co/DST7HdSq2O
January 11th 2018, 5:01pm
mikea1028 @mikea1028
RT @biotechfan20: Seeking Alpha article $OSIR:Expecting Better in 2018 https://t.co/7QCvlMNTQU
January 9th 2018, 11:01am
biotechfan20 @biotechfan20
@WallStreetTitan See Cartiform by $OSIR
January 9th 2018, 10:01am
biotechfan20 @biotechfan20
Seeking Alpha article $OSIR:Expecting Better in 2018 https://t.co/7QCvlMNTQU
January 9th 2018, 10:01am
biotechfan20 @biotechfan20
Seeking Alpha: $OSIR Solutions to Challenging Problems https://t.co/SYj0zBHH7Y
January 6th 2018, 5:01pm
ledgerzette @ledgerzette
Contrasting Anavex Life Sciences $AVXL and Osiris Therapeutics $OSIR https://t.co/PaTMbRkFAT
January 2nd 2018, 9:01am
1MinuteStock @1MinuteStock
We calculated 63-day Expected Return of $OSIR for you: 35.02% https://t.co/HIsAjjaSmk
December 30th 2017, 8:12pm
1MinuteStock @1MinuteStock
Not sure what to do with $OSIR? Explore our #fundamental pros and cons. https://t.co/aMGJOdXplb
December 30th 2017, 7:12pm
1MinuteStock @1MinuteStock
Recommendation #HOLD for $OSIR with UB rating - 2.32 out of 5. https://t.co/5zu0hCrbj3
December 30th 2017, 6:12pm
midetimes @midetimes
Contrasting Osiris Therapeutics $OSIR and Trillium Therapeutics $TRIL https://t.co/Jz6rS6KlJC
December 20th 2017, 11:12pm
dailypoliticaln @dailypoliticaln
Contrasting Osiris Therapeutics $OSIR and Trillium Therapeutics $TRIL https://t.co/syk10eZmk4
December 20th 2017, 11:12pm
WKRBNews @WKRBNews
Contrasting Osiris Therapeutics $OSIR and Trillium Therapeutics $TRIL https://t.co/ddzKTdmo2N
December 20th 2017, 11:12pm
dailymailtimes @dailymailtimes
Contrasting Osiris Therapeutics $OSIR and Trillium Therapeutics $TRIL https://t.co/gQlqj1edpm
December 20th 2017, 10:12pm
storminvestor @storminvestor
Reviewing Osiris Therapeutics $OSIR & Anavex Life Sciences $AVXL https://t.co/B1hPQKULZ7
December 20th 2017, 8:12pm
SPNewsAnalysis @SPNewsAnalysis
Reviewing Osiris Therapeutics $OSIR & Anavex Life Sciences $AVXL https://t.co/vNNt8OQUvW
December 20th 2017, 8:12pm
TickerReport @TickerReport
Comparing Osiris Therapeutics $OSIR and Trillium Therapeutics $TRIL https://t.co/ooQHnN1fYR
December 18th 2017, 4:12pm
emq_news @emq_news
Comparing Osiris Therapeutics $OSIR and Trillium Therapeutics $TRIL https://t.co/ijScgLBjjS
December 18th 2017, 4:12pm
TickerReport @TickerReport
Comparing Osiris Therapeutics $OSIR and Trillium Therapeutics $TRIL https://t.co/3vYT3GGahO
December 18th 2017, 4:12pm
biotechfan20 @biotechfan20
$OSIR: Expecting Better in 2018 https://t.co/7QCvlMNTQU https://t.co/ftSciGk68N
December 14th 2017, 4:12pm
dakotafinancial @dakotafinancial
Head to Head Analysis: Anavex Life Sciences $AVXL and Osiris Therapeutics $OSIR https://t.co/gXIrxouDiH
December 13th 2017, 9:12am
CFinancialNews @CFinancialNews
Head to Head Analysis: Anavex Life Sciences $AVXL and Osiris Therapeutics $OSIR https://t.co/q1THq6IUJ9
December 13th 2017, 9:12am
ConsumerFeed @ConsumerFeed
Head to Head Analysis: Anavex Life Sciences $AVXL and Osiris Therapeutics $OSIR https://t.co/AX3CCBtVvz
December 13th 2017, 9:12am
AmericanBanking @AmericanBanking
Head to Head Analysis: Anavex Life Sciences $AVXL and Osiris Therapeutics $OSIR https://t.co/tfQFrdRl8Z
December 13th 2017, 9:12am
ConsumerFeed @ConsumerFeed
Head to Head Analysis: Osiris Therapeutics $OSIR vs. Trillium Therapeutics $TRIL https://t.co/wWu1j04zy0 #acn
December 13th 2017, 3:12am
ZarVicBrothers @ZarVicBrothers
RT @WatchlistN: Head to Head Analysis: Osiris Therapeutics $OSIR vs. Trillium Therapeutics $TRIL https://t.co/FY3YQ7krMx
December 13th 2017, 3:12am
ZarVicBrothers @ZarVicBrothers
RT @intercooleronli: Head to Head Analysis: Osiris Therapeutics $OSIR vs. Trillium Therapeutics $TRIL https://t.co/xpGZm01wOY
December 13th 2017, 3:12am
AmericanBanking @AmericanBanking
Head to Head Analysis: Osiris Therapeutics $OSIR vs. Trillium Therapeutics $TRIL https://t.co/UxwDwHFsVv
December 13th 2017, 3:12am
WatchlistN @WatchlistN
Head to Head Analysis: Osiris Therapeutics $OSIR vs. Trillium Therapeutics $TRIL https://t.co/FY3YQ7krMx
December 13th 2017, 3:12am
intercooleronli @intercooleronli
Head to Head Analysis: Osiris Therapeutics $OSIR vs. Trillium Therapeutics $TRIL https://t.co/xpGZm01wOY
December 13th 2017, 3:12am
CFinancialNews @CFinancialNews
Head to Head Analysis: Osiris Therapeutics $OSIR vs. Trillium Therapeutics $TRIL https://t.co/8ukEFZHR1i
December 13th 2017, 3:12am
biotechfan20 @biotechfan20
$OSIR overview on Seeking Alpha "Osiris Therapeutics: Expecting Better in 2018" https://t.co/7QCvlMNTQU
December 12th 2017, 9:12pm
biotechfan20 @biotechfan20
Osiris Therapeutics: Expecting Better In 2018 https://t.co/7QCvlMNTQU $OSIR #impactinvesting #biotech… https://t.co/p4bTfRJOfU
December 7th 2017, 8:12pm
newswithvalue @newswithvalue
$OSIR: Osiris Therapeutics: Expecting Better In 2018: https://t.co/QI9HQxa5gV
December 7th 2017, 12:12pm
StockTexts @StockTexts
$OSIR Osiris Therapeutics, Inc. SEC Filing: Form 8-K https://t.co/oKUPIoSxSo
December 5th 2017, 4:12pm
confcalltran @confcalltran
Update on Government https://t.co/6dWfyrHZm8 $OSIR
December 5th 2017, 4:12pm
SFTW_Trader @SFTW_Trader
SFTW Trader short-term Recommendation: $OSIR Osiris Therapeutics #stocks https://t.co/rNfVyCfhYS
December 5th 2017, 9:12am
biotechfan20 @biotechfan20
Regeneration of Osiris Therapeutics https://t.co/sBHwsDfqTC $OSIR #impactinvesting
December 5th 2017, 8:12am
SwingTradeOTC @SwingTradeOTC
Scan results - Bullish Engulfing today: $WMMVY $OSIR ... https://t.co/AhU0eWGOEB
December 4th 2017, 7:12pm
TheMarketsDaily @TheMarketsDaily
Analyzing Osiris Therapeutics $OSIR & Anavex Life Sciences $AVXL https://t.co/fTniUr5ftW
November 29th 2017, 11:11pm
biotechfan20 @biotechfan20
Regeneration of Osiris Therapeutics https://t.co/sBHwsDfqTC $OSIR
November 29th 2017, 7:11am
livetraderalrt @livetraderalrt
$OSIR Update in Lawsuit for Investors in Osiris Therapeutics, Inc. (NASDAQ: OSIR) Shares Announced by Shareholders… https://t.co/pPVyMawxLA
November 28th 2017, 11:11am
dailypoliticaln @dailypoliticaln
Head-To-Head Contrast: Osiris Therapeutics $OSIR versus Grifols $GRFS https://t.co/NOoKytdv6C
November 28th 2017, 10:11am
midetimes @midetimes
Head-To-Head Contrast: Osiris Therapeutics $OSIR versus Grifols $GRFS https://t.co/EeQFLPXcC2
November 28th 2017, 10:11am
WKRBNews @WKRBNews
Head-To-Head Contrast: Osiris Therapeutics $OSIR versus Grifols $GRFS https://t.co/hHytvNqHDz
November 28th 2017, 10:11am
dailymailtimes @dailymailtimes
Head-To-Head Contrast: Osiris Therapeutics $OSIR versus Grifols $GRFS https://t.co/Q52F3ktc8s
November 28th 2017, 10:11am
biotechfan20 @biotechfan20
Will $MESO success with MSC-100-IV for acute graft versus host disease (TEMCELL® in Japan) lead to more royalty income for $OSIR?
November 27th 2017, 8:11pm

Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.